MHC-based vaccination approaches: Progress and perspectives

Expert Reviews in Molecular Medicine

Volumn 5, Issue 7, 2003, Pages

  Mehra, Narinder K ^a   Kaur, Gurvinder ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

AH8.1; CCR5; genetic diversity; HIV; HLA; human immunodeficiency virus; human leukocyte antigen; major histocompatibility complex; MHC; vaccine

Indexed keywords

EPITOPE; HISTOCOMPATIBILITY ANTIGEN; HLA ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNOLOGY; REVIEW; TOPOGRAPHY;

AIDS VACCINES; EPITOPES; HISTOCOMPATIBILITY ANTIGENS; HIV ANTIGENS; HLA ANTIGENS; HUMANS; T-LYMPHOCYTES, CYTOTOXIC; TOPOGRAPHY, MEDICAL;

EID: 84867491795     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1462399403005957     Document Type: Review

References (86)

1. Mehra, N.K. and Kaur, G. (2000) Perspectives in New Biology and Molecular Medicine. Mol. Asp. Immunobiol. 1, 4-7
2. McCluskey, J. and Peh, C.A. (1999) The human leucocyte antigens and clinical medicine: an overview. Rev Immunogenet 1, 3-20, PubMed: 21151066
3. MacDonald, K.S. et al. (2001) Human leucocyte antigen supertypes and immune susceptibility to HIV-1, implications for vaccine design. Immunol Lett 79, 151-157, PubMed: 21479471 (Pubitemid 32938220)
4. IMGT Database. http://www.ebi.ac.uk/imgt/index.html
5. Viret, C. and Janeway, C.A., Jr. (1999) MHC and T cell development. Rev Immunogenet 1, 91-104, PubMed: 21151072
6. Haynes, B.F. (1996) HIV vaccines: where we are and where we are going. Lancet 348, 933-937, PubMed: 97000759 (Pubitemid 26333853)
7. Sette, A. and Sidney, J. (1999) Nine major HLA class I supertypes account for the vast preponderance of HLA-A and-B polymorphism. Immunogenetics 50, 201-212, PubMed: 20069578 (Pubitemid 30099525)
8. Moore, C.B. et al. (2002) Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296, 1439-1443, PubMed: 22025700 (Pubitemid 34553083)
9. McMichael, A. and Klenerman, P. (2002) HIV/AIDS. HLA leaves its footprints on HIV. Science 296, 1410-1411, PubMed: 22025692 (Pubitemid 34553075)
10. Joint United Nations Programme on HIV/AIDS (2002) Report on the Global HIV/AIDS Epidemic. http://www.unaids.org/barcelona/presskit/embargo.htm
11. Chakraborty, M.S. and Chakraborty, A. (2000) Tuberculosis and HIV illness. J Indian Med Assoc 98, 103-106, 109, PubMed: 20470162
12. Al Jabri, A.A. (2002) HLA and in vitro susceptibility to HIV infection. Mol Immunol 38, 959-967, PubMed: 22007733 (Pubitemid 34496955)
13. Shiina, T. et al. (1999) Genome sequencing analysis of the 1.8 Mb entire human MHC class I region. Immunol Rev 167, 193-199, PubMed: 99252819 (Pubitemid 29178981)
14. Shiina, T. et al. (1999) Molecular dynamics of MHC genesis unraveled by sequence analysis of the 1,796,938-bp HLA class I region. Proc Natl Acad Sci USA 96, 13282-13287, PubMed: 20027539
15. Hudrisier, D. and Bongrand, P. (2002) Intercellular transfer of antigen-presenting cell determinants onto T cells: molecular mechanisms and biological significance. Faseb J 16, 477-486, PubMed: 21917003 (Pubitemid 34273231)
16. Milner, C.M. and Campbell, R.D. (2001) Genetic organization of the human MHC class III region. Front Biosci 6, D914-926, PubMed: 21379961
17. Stern, L.J. and Wiley, D.C. (1994) Antigenic peptide binding by class I and class II histocompatibility proteins. Structure 2, 245-251, PubMed: 94373496
18. Bjorkman, P.J. and Burmeister, W.P. (1994) Structures of two classes of MHC molecules elucidated: crucial differences and similarities. Curr Opin Struct Biol 4, 852-856, PubMed: 95227818
19. Sidney, J. et al. (1997) The HLA-A*0207 peptide binding repertoire is limited to a subset of the A*0201 repertoire. Hum Immunol 58, 12-20, PubMed: 98101102 (Pubitemid 28027409)
20. Madden, D.R. (1995) The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 13, 587-622, PubMed: 95336691
21. Vasmatzis, G. et al. (1996) Computational determination of side chain specificity for pockets in class I MHC molecules. Mol Immunol 33, 1231-1239, PubMed: 97275265 (Pubitemid 27138066)
22. Vasmatzis, G. et al. (1996) TcR recognition of the MHC-peptide dimer: structural properties of a ternary complex. J Mol Biol 261, 72-89, PubMed: 96335205 (Pubitemid 26270784)
23. Matsui, M., Hioe, C.E. and Frelinger, J.A. (1993) Roles of the six peptide-binding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones. Proc Natl Acad Sci USA 90, 674-678, PubMed: 93133849 (Pubitemid 23028926)
24. Matsui, M. et al. (1994) Significance of the six peptide-binding pockets of HLA-A2.1 in influenza A matrix peptide-specific cytotoxic T-lymphocyte reactivity. Hum Immunol 41, 160-166, PubMed: 95164263 (Pubitemid 24332762)
25. Bouvier, M. and Wiley, D.C. (1994) Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. Science 265, 398-402, PubMed: 94294811 (Pubitemid 24259973)
26. Matsumura, M. et al. (1992) Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257, 927-934, PubMed: 92367004
27. DiBrino, M. et al. (1994) Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8. J Immunol 152, 620-631, PubMed: 94110616
28. Garrett, T.P. et al. (1989) Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 342, 692-696, PubMed: 90081842
29. Newton-Nash, D.K. and Eckels, D.D. (1993) Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides. J Immunol 150, 1813-1821, PubMed: 93171606 (Pubitemid 23129657)
30. Woolley, A.T. and Mathies, R.A. (1994) Ultra-high-speed DNA fragment separations using microfabricated capillary array electrophoresis chips. Proc Natl Acad Sci USA 91, 11348-11352, PubMed: 95062265 (Pubitemid 24356341)
31. Poland, G.A. et al. (2001) The role of mass spectrometry in vaccine development. Vaccine 19, 2692-2700, PubMed: 21157792 (Pubitemid 32234291)
32. Dhodapkar, K.M. et al. (2002) Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific killer T cells by dendritic cells. J Exp Med 195, 125-133, PubMed: 21640538 (Pubitemid 34074502)
33. Moudgil, K.D. et al. (1996) Unresponsiveness to a self-peptide of mouse lysozyme owing to hindrance of T cell receptor-major histocompatibility complex/peptide interaction caused by flanking epitopic residues. J Exp Med 183, 535-546, PubMed: 96195206 (Pubitemid 26059517)
34. Nelson, D., Bundell, C. and Robinson, B. (2000) In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes. J Immunol 165, 6123-6132, PubMed: 20540065
35. van Endert, P.M. (2001) Designing peptide vaccines for cellular cross-presentation. Biologicals 29, 285-288, PubMed: 21840735 (Pubitemid 34093654)
36. Reisner, Y. (2001) Stem cell transplantation across major genetic barriers. Ann N Y Acad Sci 938, 322-326; discussion 326-327, PubMed: 21352165
37. Qi, Y. et al. (1996) Hybrid antibody mediated veto of cytotoxic T lymphocyte responses. J Exp Med 183, 1973-1980, PubMed: 96235007 (Pubitemid 26158889)
38. Sahni, A.K., Prasad, V.V. and Seth, P. (2002) Genomic diversity of human immunodeficiency virus type-1 in India. Int J STD AIDS 13, 115-118, PubMed: 21828987 (Pubitemid 34135477)
39. 325 recognized Indian languages. http://www.sanyal.com/india/indlang.html
40. Jaini, R., Kaur, G. and Mehra, N.K. (2002) Heterogeneity of HLA-DRB1*04 and its associated haplotypes in the North Indian population. Hum Immunol 63, 24-29, PubMed: 21912968 (Pubitemid 34074633)
41. Mehra, N.K. et al. (2001) Molecular diversity of HLA-A*02 in Asian Indians: predominance of A*0211. Tissue Antigens 57, 502-507, PubMed: 21442093 (Pubitemid 32783721)
42. Jaini, R. et al. (2002) Molecular diversity of the HLA-A*19 group of alleles in North Indians: Possible oriental influence. Tissue Antigens 59, 487-491, PubMed: 22337829 (Pubitemid 35034468)
43. Jaini, R. et al. (2002) External genetic influences on MHC diversity in Asian Indians. In HLA 2002 Immunobiology of the Human MHC; Proceedings of the 13th International Histocompatibility Workshop and Conference, Seattle 2002. (Hansen, J.A. and Dupont, B., eds), IHWG Press, Washington, USA (in press)
44. Kaur, G. et al. (2002) Paediatric Celiac disease in India is associated with multiple DR3-DQ2 haplotypes. Hum Immunol 63, 677-682, PubMed: 12121676 (Pubitemid 34816111)
45. Mehra, N.K. et al. (2002) Immunogenetics of autoimmune diseases in Asian Indians. Ann N Y Acad Sci 958, 333-336, PubMed: 22015058 (Pubitemid 34592257)
46. Sezerman, U., Vajda, S. and DeLisi, C. (1996) Free energy mapping of class I MHC molecules and structural determination of bound peptides. Protein Sci 5, 1272-1281, PubMed: 96416254 (Pubitemid 26239435)
47. Roger, M. (1998) Influence of host genes on HIV-1 disease progression. Faseb J 12, 625-632, PubMed: 98280741 (Pubitemid 28247142)
48. Carrington, M. et al. (1999) HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283, 1748-1752, PubMed: 99174091
49. Flores-Villanueva, P.O. et al. (2001) Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci USA 98, 5140-5145, PubMed: 21221092 (Pubitemid 32397096)
50. Martin, M.P. et al. (2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31, 429-434, PubMed: 22144565 (Pubitemid 35154456)
51. Gao, X. et al. (2001) Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 344, 1668-1675, PubMed: 21253957 (Pubitemid 32479964)
52. Swann, S.A. et al. (2001) HIV-1 Nef blocks transport of MHC class I molecules to the cell surface via a PI 3-kinase-dependent pathway. Virology 282, 267-277, PubMed: 21186341 (Pubitemid 32881154)
53. Emerman, M. and Malim, M.H. (1998) HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. Science 280, 1880-1884, PubMed: 98296350 (Pubitemid 28299384)
54. Stumptner-Cuvelette, P. et al. (2001) HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc Natl Acad Sci USA 98, 12144-12149, PubMed: 21477443 (Pubitemid 32959841)
55. Steel, C.M. et al. (1988) HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet 1, 1185-1188, PubMed: 88215862
56. Candore, G. et al. (1998) Biological basis of the HLA-B8,DR3-associated progression of acquired immune deficiency syndrome. Pathobiology 66, 33-37, PubMed: 98237074 (Pubitemid 28140600)
57. Kaul, R. et al. (2001) New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol Lett 79, 3-13, PubMed: 21479453 (Pubitemid 32938202)
58. Kaul, R. et al. (2001) CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. J Clin Invest 107, 1303-1310, PubMed: 21269449 (Pubitemid 32494547)
59. Kaslow, R.A. et al. (1990) A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study. Lancet 335, 927-930, PubMed: 90220114 (Pubitemid 20134966)
60. Lockett, S.F. et al. (2001) Mismatched human leukocyte antigen alleles protect against heterosexual HIV transmission. J Acquir Immune Defic Syndr 27, 277-280, PubMed: 21356716 (Pubitemid 32661970)
61. Bisset, L.R. (1994) Molecular mimicry in the pathogenesis of AIDS: the HIV/MHC/mycoplasma triangle. Med Hypotheses 43, 388-396, PubMed: 95257805
62. Tang, J. et al. (2002) Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression. J Virol 76, 662-672, PubMed: 21624266 (Pubitemid 34033365)
63. Clapham, P.R. and McKnight, A. (2001) HIV-1 receptors and cell tropism. Br Med Bull 58, 43-59, PubMed: 21571324 (Pubitemid 33070763)
64. Dejucq, N. (2000) HIV-1 replication in CD4+ T cell lines: the effects of adaptation on co-receptor use, tropism, and accessory gene function. J Leukoc Biol 68, 331-337, PubMed: 20439381
65. Alfano, M. and Poli, G. (2001) Cytokine and chemokine based control of HIV infection and replication. Curr Pharm Des 7, 993-1013, PubMed: 21365489 (Pubitemid 32624430)
66. De Clercq, E. (2001) New developments in anti-HIV chemotherapy. Curr Med Chem 8, 1543-1572, PubMed: 21446451 (Pubitemid 33076802)
67. Simmons, G. et al. (2000) Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands. Immunol Rev 177, 112-126, PubMed: 21019725
68. Sheppard, H.W. et al. (2002) HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion. J Acquir Immune Defic Syndr 29, 307-313, PubMed: 21861850 (Pubitemid 34208541)
69. Lu, Y. et al. (1999) Genotype and allele frequency of a 32-base pair deletion mutation in the CCR5 gene in various ethnic groups: absence of mutation among Asians and Pacific Islanders. Int J Infect Dis 3, 186-191, PubMed: 20045124
70. Huang, Y. et al. (1996) The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 2, 1240-1243, PubMed: 97054455 (Pubitemid 26375409)
71. Husain, S. et al. (1998) First report of a healthy Indian heterozygous for delta 32 mutant of HIV-1 co-receptor-CCR5 gene. Gene 207, 141-147, PubMed: 98172746 (Pubitemid 28085343)
72. Ramana, G.V. et al. (2001) Distribution of HIV-1 resistance-conferring polymorphic alleles SDF-1-3'A, CCR2-64I and CCR5-Delta32 in diverse populations of Andhra Pradesh, South India. J Genet 80, 137-140, PubMed: 21984192 (Pubitemid 33572487)
73. Majumder, P.P. and Dey, B. (2001) Absence of the HIV-1 protective Delta ccr5 allele in most ethnic populations of India. Eur J Hum Genet 9, 794-796, PubMed: 21640251 (Pubitemid 33014593)
74. Goila, R., Kumar, F. and Banerjea, A.C. (2001) MIP-1 alpha promoter polymorphism in humans and monkeys: identification of two polymorphic regions characterized by the insertion of unique sequences in monkeys. Aids 15, 1065-1067, PubMed: 21292354 (Pubitemid 32476678)
75. Ramamoorti, N. et al. (2001) High frequency of G to A transition mutation in the stromal cell derived factor-1 gene in India, a chemokine that blocks HIV-1 (X4) infection: multiple proteins bind to 3'-untranslated region of SDF-1 RNA. Genes Immun 2, 408-410, PubMed: 21560697 (Pubitemid 33674258)
76. Vicenzi, E. et al. (2000) CCR2-64I polymorphism, syncytium-inducing human immunodeficiency virus strains, and disease progression. J Infect Dis 182, 1579-1580, PubMed: 20478023
77. Kostrikis, L.G. et al. (1998) A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 4, 350-353, PubMed: 98160248 (Pubitemid 28144097)
78. Chakrabarti, B.K. et al. (2002) Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization. J Virol 76, 5357-5368, PubMed: 21988467 (Pubitemid 34517886)
79. Rossi, J.J. (1999) The application of ribozymes to HIV infection. Curr Opin Mol Ther 1, 316-322, PubMed: 21570756 (Pubitemid 29309179)
80. Shahi, S., Shanmugasundaram, G.K. and Banerjea, A.C. (2001) Ribozymes that cleave reovirus genome segment S1 also protect cells from pathogenesis caused by reovirus infection. Proc Natl Acad Sci USA 98, 4101-4106, PubMed: 21173692 (Pubitemid 32249905)
81. Rodenburg, C.M. et al. (2001) Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents. AIDS Res Hum Retroviruses 17, 161-168, PubMed: 21094715 (Pubitemid 32099300)
82. Cecilia, D. et al. (2000) Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India. Virology 271, 253-258, PubMed: 20319110 (Pubitemid 30461303)
83. Betts, M.R. et al. (1997) Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians. J Virol 71, 8908-8911, PubMed: 98001422 (Pubitemid 27446481)
84. Cao, H. et al. (1997) Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development. J Virol 71, 8615-8623, PubMed: 98001384 (Pubitemid 27446443)
85. Threlkeld, S.C. et al. (1997) Degenerate and promiscuous recognition by CTL of peptides presented by the MHC class I A3-like superfamily: implications for vaccine development. J Immunol 159, 1648-1657, PubMed: 97400330 (Pubitemid 127484148)
86. Migueles, S.A. et al. (2000) HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA 97, 2709-2714, PubMed: 10694578 (Pubitemid 30159236)